![Society of Urologic Oncology (SUO) Fellowship | Roswell Park Comprehensive Cancer Center - Buffalo, NY Society of Urologic Oncology (SUO) Fellowship | Roswell Park Comprehensive Cancer Center - Buffalo, NY](https://www.roswellpark.org/sites/default/files/2020-09/kauffman-and-fellow-urology_0.jpg)
Society of Urologic Oncology (SUO) Fellowship | Roswell Park Comprehensive Cancer Center - Buffalo, NY
Xtalks Webinars - Join this webinar by Certis Oncology to learn about the future of glioblastoma research and how to overcome challenges with glioblastoma drug development. https://buff.ly/3w4dRuU #Cancer #Oncology #Glioblastoma | Facebook
![Celyad Oncology on Twitter: "We've just published our third quarter financial results and business updates- read more here: https://t.co/v17TdqQdhQ $CYAD https://t.co/7l4FGUbct3" / Twitter Celyad Oncology on Twitter: "We've just published our third quarter financial results and business updates- read more here: https://t.co/v17TdqQdhQ $CYAD https://t.co/7l4FGUbct3" / Twitter](https://pbs.twimg.com/media/FhM_T1sWQAAQWxw.jpg:large)
Celyad Oncology on Twitter: "We've just published our third quarter financial results and business updates- read more here: https://t.co/v17TdqQdhQ $CYAD https://t.co/7l4FGUbct3" / Twitter
Oncology Learning Network - #Selpercatinib was shown to be effective, with manageable safety, in #patients with RET+ medullary thyroid cancer in a phase 1/2 trial. Learn More: https://buff.ly/3onUIxp | Facebook
![Jonathan Licht, MD on Twitter: "Congrats to the @UFRadOnc research team led by Dr. Julie Bradley for being awarded $147,573 by @ConquerCancerFd to study inequities in the delivery of care & outcomes Jonathan Licht, MD on Twitter: "Congrats to the @UFRadOnc research team led by Dr. Julie Bradley for being awarded $147,573 by @ConquerCancerFd to study inequities in the delivery of care & outcomes](https://pbs.twimg.com/media/FIvvdpKX0AAUqcu.jpg:large)
Jonathan Licht, MD on Twitter: "Congrats to the @UFRadOnc research team led by Dr. Julie Bradley for being awarded $147,573 by @ConquerCancerFd to study inequities in the delivery of care & outcomes
![NCI Treatment on Twitter: "Hello from Dr. Doroshow, DCTD's Director. We are announcing a new @theNCI research resource for the scientific community called ROADMAPS - Responses to Oncology Agents and Dosing in NCI Treatment on Twitter: "Hello from Dr. Doroshow, DCTD's Director. We are announcing a new @theNCI research resource for the scientific community called ROADMAPS - Responses to Oncology Agents and Dosing in](https://pbs.twimg.com/media/FUvsy48VEAAYoeO.jpg:large)